Timing of Levodopa Treatment in Parkinson's Disease

• Status: Completed
• Trial end date: 2004-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The ELLDOPA study is a controlled clinical trial in patients with newly diagnosed PD to determine the optimal timing and dosing with levodopa (Sinemet or its generic equivalents).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
• Treatments: Levodopa

Criteria

Inclusion Criteria:

• Early, mild PD, not requiring medications

• Age 30 or older

• Duration from time of diagnosis of PD: less than 2 years

• Hoehn & Yahr Stage 1 or 2

• Exposure to levodopa or dopamine agonist of 14 days or less